C07C 233/18
Having the carbon atom of the carboxamide group bound to a hydrogen
Official title: having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
C07C233/18 (Having the carbon atom of the carboxamide group bound to a hydrogen) appears on 588 US grants and 493 published applications in this corpus.
Search patents in C07C- Granted patents
- 588
- Published applications
- 493
- Assignees
- 333
- Inventors
- 1,488
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 8 | 0 |
| 1991 | 12 | 0 |
| 1992 | 17 | 0 |
| 1993 | 12 | 0 |
| 1994 | 13 | 0 |
| 1995 | 11 | 0 |
| 1996 | 30 | 0 |
| 1997 | 28 | 0 |
| 1998 | 24 | 0 |
| 1999 | 17 | 0 |
| 2000 | 20 | 0 |
| 2001 | 16 | 6 |
| 2002 | 16 | 14 |
| 2003 | 14 | 9 |
| 2004 | 8 | 18 |
| 2005 | 7 | 18 |
| 2006 | 11 | 19 |
| 2007 | 12 | 16 |
| 2008 | 13 | 25 |
| 2009 | 14 | 13 |
| 2010 | 15 | 30 |
| 2011 | 15 | 17 |
| 2012 | 16 | 29 |
| 2013 | 16 | 21 |
| 2014 | 25 | 26 |
| 2015 | 25 | 34 |
| 2016 | 24 | 23 |
| 2017 | 21 | 22 |
| 2018 | 13 | 14 |
| 2019 | 12 | 21 |
| 2020 | 15 | 24 |
| 2021 | 15 | 24 |
| 2022 | 14 | 14 |
| 2023 | 14 | 15 |
| 2024 | 15 | 10 |
| 2025 | 7 | 18 |
| 2026 | 9 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tricine and citric acid lipids4 Aug 2026US 12,697,302 B2Translate Bio, Inc.
- Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same4 Aug 2026US 12,698,254 B2Geron Corporation
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Lipids and lipid nanoparticle formulations for delivery of nucleic acids30 Jun 2026US 12,667,627 B2Acuitas Therapeutics, Inc.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Crystalline form of ceramide np and composition including the same24 Sep 2026US 2026/0283927 A1Croda Korea Ltd
- Camelid-Derived Bioactive Compounds: Compositions, Methods, and Therapeutic Analgesic Applications17 Sep 2026US 2026/0272992 A1Applied Bio Research Inc.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium27 Aug 2026US 2026/0250591 A1Resonac Corporation
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium27 Aug 2026US 2026/0250595 A1Resonac Corporation
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Polyethyleneglycol-modified lipid compounds and uses thereof224US 7,803,397 B2Protiva Biotherapeutics, Inc. · 2010
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Photolabile compounds and methods for their use151US 5,739,386 AAffymax Technologies N.V. · 1998